Application
ZP3 Antibody (C-term) western blot analysis in human placenta tissue lysates (35ug/lane).This demonstrates the ZP3 antibody detected the ZP3 protein (arrow).| Product Name | ZP3 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | ZP3; ZP3A; ZP3B; ZPC; Zona pellucida sperm-binding protein 3; Sperm receptor; ZP3A/ZP3B; Zona pellucida glycoprotein 3; Zona pellucida protein C; Processed zona pellucida sperm-binding protein 3 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | ZP3A ZP3B ZPC |
|---|---|
| Alternative Names | ZP3 ZP3A ZP3B ZPC Zona pellucida sperm-binding protein 3 Sperm receptor ZP3A/ZP3B Zona pellucida glycoprotein 3 Zona pellucida protein C Processed zona pellucida sperm-binding protein 3 |
| Molecular Weight(MW) | 47018 Da |
| Function | The mammalian zona pellucida, which mediates species- specific sperm binding, induction of the acrosome reaction and prevents post-fertilization polyspermy, is composed of three to four glycoproteins, ZP1, ZP2, ZP3, and ZP4. ZP3 is essential for sperm binding and zona matrix formation |
| Tissue Specificity | Oocytes. |
| Cellular Localization | Processed zona pellucida sperm-binding protein 3: Secreted, extracellular space, extracellular matrix |
| Entrez Gene | 7784 |
|---|---|
| Nucleotide Accession | NP_001103824.1 NP_009086.4 |
Application
ZP3 Antibody (C-term) western blot analysis in human placenta tissue lysates (35ug/lane).This demonstrates the ZP3 antibody detected the ZP3 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
